Black Diamond Therapeutics (NASDAQ:BDTX) Trading Down 1.1% - Here's What HappenedMarket Beat·Jul 17 at 11:40 PMBDTX-5.68%
Biotech and CXO Clinical Momentum: 7 Core Companies Set for Late-2026 BreakoutsGlobal Report·Jul 9 at 05:02 AMBVS-0.68%ALT-2.34%
Black Diamond Therapeutics holds annual stockholder meeting via webcastPUBT·Jun 29 at 03:21 PMBDTX-5.68%
Black Diamond Therapeutics Touts Silevertinib Lung Cancer Data, Eyes FDA PathMarket Beat·Jun 6 at 04:04 AMBDTX-5.68%
What's Going On With Black Diamond Therapeutics Stock Tuesday?benzinga_article·May 26 at 10:31 AMBDTX-5.68%PBE-0.66%
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·May 22 at 12:05 PMAKTX-2.14%NGEN-1.24%
Black Diamond Plunges Despite Positive Phase 2 Results For Silevertinib In 1L NSCLCnasdaq·May 22 at 03:20 AMBDTX-5.68%IBB-1.04%
U.S. Stock Movement Update: Workday rises over 10%, Black Diamond Therapeutics falls nearly 11%Price Alert·May 21 at 09:00 PMWDAY+5.21%BDTX-5.68%
U.S. Stock Movement Update: Workday rises 11.42%, Black Diamond Therapeutics falls 13.80% attracting attentionPrice Alert·May 21 at 08:00 PMWDAY+5.21%BDTX-5.68%
Black Diamond Therapeutics Lung Cancer Drug Shows 15.2-Month PFS in Phase 2 StudyMarket Beat·May 21 at 06:09 PMBDTX-5.68%IXJ-0.41%
Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations | BDTX Stock NewsStockTitan·May 21 at 08:15 AMBDTX-5.68%LABU-4.04%
MTVA Gains Weight, CODX Takes A Shot At Ebola, EDSA To Reveal New Data, BDTX On Watchrttnews·May 20 at 04:04 AMADIL+6.78%BDTX-5.68%
